Treatment patterns, adverse events, healthcare resource use and costs among commercially insured patients with mantle cell lymphoma in the United States.

A generalized linear model, controlling for demographic and clinical characteristics and regimen, showed a trend toward higher total all‐cause cost PPPM as the number of incident AEs increased (cost ratio [CR] = 1.1, 95% CI 1.1‐1.2, P < .0001; Table S3 ).

also in 53,322 other papers